Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Withdraws Pre-Term Birth Drug

Roughly 1 in 10 infants born in the U.S. are preterm, placing both the baby and mother at higher risk of death or disability.

221019 Makena Mn 1000 D9738f Df7de5

According to a recent CNN article, the FDA has withdrawn its approval of Makena, a drug approved over a decade ago to reduce the risk of preterm birth, which had been the only medication approved for the condition. The FDA says the drug isn’t effective, and its benefits don’t outweigh the risks. The drug disproportionately affects Black women, for whom the rate of preterm birth is about 50% higher than for White or Hispanic women. Preterm birth has also been a growing problem in the US, with the rate rising from 10.1% in 2020 to 10.5% in 2021.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO